GB2188728A - Specific binding assays - Google Patents

Specific binding assays Download PDF

Info

Publication number
GB2188728A
GB2188728A GB08708200A GB8708200A GB2188728A GB 2188728 A GB2188728 A GB 2188728A GB 08708200 A GB08708200 A GB 08708200A GB 8708200 A GB8708200 A GB 8708200A GB 2188728 A GB2188728 A GB 2188728A
Authority
GB
United Kingdom
Prior art keywords
enzyme
pqq
analyte
binding member
gdh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08708200A
Other versions
GB8708200D0 (en
Inventor
Anthony Peter Francis Turner
Sharon Lynne Miller
Costa Eric Joseph D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cranfield Institute of Technology
Original Assignee
Cranfield Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cranfield Institute of Technology filed Critical Cranfield Institute of Technology
Publication of GB8708200D0 publication Critical patent/GB8708200D0/en
Publication of GB2188728A publication Critical patent/GB2188728A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

An analyte is detected in an enzyme-linked assay, wherein the presence of a first enzyme is related to the amount of analyte. The first enzyme converts an inactive precursor of PQQ to PQQ or an active analogue thereof. The PQQ complements an apo-enzyme such as apo-GDH to form an active second enzyme (GDH). The second enzyme catalyses a reaction leading to a detectable signal. This signal is preferably measured bioelectrochemically such as by a GDH electrode as shown in Fig. 1. <IMAGE>

Description

SPECIFICATION Specific binding assays The present invention relates to specific binding assays.
The present invention seeks to provide improvements in assays for specific binding wherein the binding is detected by a signal generated by a secondary event dependent on the extent of binding. The signal, of the present invention, is generated by the reconstitution of a holoenzyme, such as the quinoprotein glucose dehydrogenase, from the apo-enzyme and co-enzyme or prosthetic group.
According to the present invention there is provided a specific binding assay for an analyte which comprises: (a) binding of a specific binding pair (sbp) to an extent related to the presence of the analyte, which sbp comprises an enzyme; (b) release of a co-enzyme from a derivative thereof by the action of said enzyme, the derivative being a substrate for said enzyme; (c) re-constitution of a holo-enzyme from the co-enzyme and an apo-enzyme; and (d) detection of the holo-enzyme; wherein the co-enzyme derivative does not combine with the apo-enzyme to reconstitute substantial holo-enzyme activity.
In a one form the co-enzyme is 2,7,9-tricarboxy-1H-pyrrolo-(2,3-flquinoline-4,5-dione (POO) or an analogue thereof which reconstitutes holo-enzyme activity, and the apo-enzyme is a quinoprotein.
Suitably, the specific binding pair comprises an immobilised binding member specific for an analyte and a second binding member conjugated to an enzyme. Suitably, the second binding member is either specific for the immobilised binding member or the analyte. For example, the second binding member may compete with the analyte for conjugation with the immobilised binding member, or the immobilised binding member may compete with the analyte for conjugation with the second binding member. Alternatively, the analyte may contain a site which binds specifically to the immobilised binding member and a different site which binds specifically to the second binding member.
Generally, the enzymic release of the co-enzyme provides primary amplification. Suitably, the holo-enzyme generates a signal, which is preferably an electrochemical signal though it also may be a spectrophotometric signal. Generally, the action of the holo-enzyme provides secondary amplification.
In order that the present invention may be more clearly understood, it will be further illustrated by way of example only and with reference to the drawings, wherein: Figure 1 shows a GDH electrode in cross-section; and Figure 2 is a graph showing a response of a PQQ depleted GDH electrode.
Applications of modified PQO and apo-GDH in specific binding assays Bacterial glucose dehydrogenase (GDH) is a member of a new, and increasingly important, quinoprotein class of dehydrogenases (Duine and Frank, 1981). Some alcohol dehydrogenases, some methanol dehydrogenases and some methylamine dehydrogenases are further examples (Duine and Frank, 1981). GDH was originally purified from Bacterium anitratum (Hauge, 1960) and it has now been found in a wide variety of gram-negative organisms (van Schie, et al., 1984).
The GDH prosthetic group, 2,7,9-tricarboxy-1 H-pyrrolo(2,3-l)-quinoline-4,5-dione (pyrroloquinoline quinone) (PQQ), was identified by two independent research groups (Salisbury, et al., 1979; Duine, et al., 1980), and has been synthesised by a number of routes (Corey and Tramontano, 1981; Gainor and Weinreb, 1981; Hendricksen and de Vries, 1985; MacKenzie, et al., 1983; Buchi, et al., 1985). Apo-GDH (GDH from which PQQ has been removed) from Acinetobacter calcoaceticus, Pseudomonas aeruginosa and Klebsiella aerogenes strains has been shown to act as a highly specific biological test for PQQ (Duine, et al., 1983). The relationship between GDH activity and PQQ concentration was linear between 2 and 60 nM, and PQQ adducts had negligible activity in this test (Duine, et al., 1983).
PQQ forms addition compounds with quinoprotein substrates, activators and stabilisers e.g.
alcohols, amines and cyanide (Dekker, et al., 1982). The chemical and electrochemical properties of a number of derivatives and analogues of PQQ have been investigated in detail (Sleath, et al., 1985). The close analogue of PQO, 7,9-didecarboxy PQQ, was shown to possess electrochemical and dynamic properties which were virtually indistinguishable from those of PQQ, but it was found to have no discernable activity with apo-GDH. However, 4,7-phenanthroline-5,6-dione, which also had similar electrochemical properties to PQQ (Eckert and Bruice, 1983) was found to produce activity with apo-GDH (Conlin, et al., 1985). However, in the reconstitution assay it was found to produce thirty times less activity than synthetic PQQ.Duine, et al (1980) demonstrated that a range of phenanthroline-diones and PQQ derivatives which were very closely related to PQQ were unable to restore the activity to apo-GDH on reconstitution. Another derivative of PQQ, the trimethyl ester (PQQTME), was synthesised (Corey and Tramontano, 1981) and used to catalyse the oxidation of alcohols in a non-enzymic system. However, this compound was not investigated for biological activity with apo-GDH.
Thus, PQQ and a variety of closely related compounds have been synthesised. Most of these have been tested for biological activity with apo-GDH but only one has shown any activity, and this was thirty times lower than that of PQQ.
The homogeneous kinetics and enzymic mechanism of GDH have been described (D'Costa, et al., 1984; D'Costa, 1986). Second order rate constants for the reduction of a number of electrochemical mediators by soluble GDH have also been determined using direct current cyclic voltammetry (D'Costa, et al., 1986). In addition, GDH has been immobilised on a porous graphite electrode in the presence of 1 ,1'-dimethylferrocene to produce a biosensor for glucose (D'Costa, et al., 1986). Furthermore, a GDH-based biosensor which had been made partially deficient in PQQ produced a six-fold increase in current over a period of two hours following the addition of 500 nM PQQ. In free solution the rate of re-association of PQQ with apo-GDH can be expected to occur more rapidly (Conlin, et al., 1985).
One example of a specific binding assay is the enzyme-linked immunosorbent assay (ELISA).
One form of the ELISA technique, involving a competitive assay using antigen-enzyme conjugate and immobilised antibody, comprises the following steps.
Immobilisation of antibody to solid phase, (ii) wash, (iii) incubate with enzyme-labelled antigen in the presence or absence of standard or sample antigen, (iv) wash, (v) incubate with enzyme substrate and determine the presence of product of the enzymatic reaction.
In accordance with the present invention, the enzyme substrate in (v) is a modified enzymati caliy inactive precursor of PQQ, which is converted by the label enzyme to PQQ or an enzymatically active analogue thereof, which is the prosthetic group of secondary apo-enzyme, which is thereby converted to the active holo-enzyme to produce the detectable signal.
From this it can be seen that the concentration of enzyme product (PQQ or active analogue) varies inversely with the concentration of the analyte being measured.
Examples of sbp's which may be used are given in Table 1 below.
Tabie 1: Examples of Specific Binding Pairs Ligand Anti-ligand antigen specific antibody antibody antigen hormone hormone receptor hormone receptor hormone polynucleotide strand complementary strand avidin biotin biotin avidin protein A immunoglobulin immunoglobulin protein A enzyme enzyme cofactor/substrate enzyme cofactor/substrate enzyme lectins carbohydrate carbohydrate lectins affinity dye protein protein affinity dye In conventional ELISA techniques the enzyme label is usually one that yields a chromogenic product in a signal-producing system, the concentration of which can be determined spectrophotometrically. In the present example, the primary reaction product (PQQ or active analogue) is measured by the extent to which GDH activity is restored by reconstitution of the holoenzyme.
GDH activity is preferably measured electrochemically though it may be measured spectrophotometrically.
An amperometric assay for GDH is shown below.
glucose > GDHox t mediatorred gluconolactone 2 GDHred )C mediat rox electrode
Electrons are passed from glucose to GDH and then to an electrode by way of a mediator.
The enzyme may either be in free solution with a soluble mediator or co-immobilised with a mediator on an electrode surface as shown in Fig. 1. In the example given below, a ferrocene derivative is used as the mediator. However, a variety of other mediators may used, as may conducting organic salts such as tetrathiafulvalene-tetraquinodimethane (TTF-TCNQ), or either of TTF or TCNO alone.
Construction of graphite electrodes Referring to Fig. 1, a GDH electrode 10 was constructed in the following manner: (i) A 2.5 cm length of 6 mm outside diameter glass tubing 12 was heated at one end 14, turned in, and flattened off without closing the tubing.
(ii) A disc 16 (6 mm diameter) was punched out of a 1 mm thick strip of porous graphite (Union Carbide, Ohio, USA) and washed twice in acetone (30 minutes for each wash with gentle agitation), once in boiling distilled water (1 hour), and dried in an air oven at 100"C.
(iii) The graphite disc 16 was glued to the modified end of the glass tubing 12 by the rim using Araldite (Ciba-Geigy Trade Mark) epoxy resin 18.
(iv) Electrical contact to the disc 16 was made by cementing to it a length of 0.2 mm insulated wire 20 using a drop of electrically conducting (silver-loaded) epoxy resin 22 (Johnson Matthey Chemicals Ltd., Royston, Herts., UK). Insulation of the electrical contact was made by covering it with an insulating resin 24 comprising a mixture of 9 parts epon resin (grade 815) and 1 part triethylenetetramine catalyst 24 (both obtained from Polysciences Inc., Warrington PA, USA) and allowing it to set at 60"C in an oven overnight.
(v) The electrode 10 was tested before use for electrical conductivity between the graphite surface 16 and the terminal wire 20.
Immobilisation of GDH onto graphite using water-soluble carbodiimide The graphite electrode 10 was supported in an inverted position while a 5 Xti drop of 1,1'dimethylferrocene/toluene solution (20 mg ml 1) was piaced on the graphite surface 16 and allowed to dry in air. This immobilises ferrocene intermediate 26 on the graphite surface. After 30 minutes at room temperature the electrode 10 was suspended vertically with the grafoil tip 16 pointing downwards. just into the surface of a 20 mg ml 1 solution of 1-cyclohexyl-3-(2 morpholinoethyl)carbodiimide-metho-p-toluenesulphonate (Sigma Chemical Company) in 200 mM sodium acetate buffer, pH 4.5 for 80 minutes at room temperature.The electrode 10 was washed by immersing the tip in 20 mM sodium acetate buffer, pH 5.5 and then suspended in 1.5 ml ice-cold GDH stock solution to immobilise GDH 28 on the electrode 10. The electrode was then immersed in a high concentrate phosphate buffer which caused the PQQ to leak out of the holo-enzyme leaving apo-GDH 28 on the electrode 10. After five hours the electrode 10 was washed as before then stored in 200 ul sodium buffer, pH 7.0 at 4"C for up to five weeks before use.
A GDH electrode made as above was used in a three-electrode system and was set at 160 mV against the standard calomel electrode. The assay was carried out in 10 mM phosphate, pH 7.0 at 28"C and in a final volume 10 ml.
Fig. 2 shows the response obtained from a PQQ depleted GDH electrode. The electrode was allowed to settle down to a low current of about 0.5 to 1 pA. Addition of 10 ,u1 1M glucose produced a minute rise, and addition of 50 z1 lmM glucose a further small rise. Addition of 5 jtl lmM PQQ produced a large response, causing the current to rise from about 1 jiA to about 5 ,xA, and taking about 2 hours to settle down.
This experiment shows the sensitivity of the electrode to very small amounts of PQQ (here 5 jil lmM PQQ diluted into 10 ml).
Further the comparatively slow reassociation kinetics displayed by the immobilised enzyme compared to that occurring in solution means that quantitative rate measurements can be made as opposed to measuring the extent of reactivation.
Additions of PQQ to blank or normal GDH electrodes produced no response, while additions of glucose to normal GDH electrodes produced normal current increases.
Modification of PQQ The structure of PQQ is shown below.
The C2, C7 and C9 carboxylic acid groups are potential sites for PQQ modification. Whilst not of catalytic importance the addition of bulky groups onto all or any of the carboxyl carbon atoms could prevent prosthetic group binding to apo-GDH due to steric hindrance. Such modification might also remove the negative charge. Therefore, If one or more of these groups is important in the binding of the prosthetic group to the active-site of GDH, the modification might abolish or seriously impair the binding interaction.
Reactive derivatives of carboxylic acid groups can be readily prepared e.g. acid chlorides, anhydrides, etc., which will undergo reaction with nucleophilic compounds such as amines or alcohols to yield amide and ester linkages respectively. An alternative method of modifying the carboxyl groups of PQQ would be the use of compounds such as carbodiimides. These activate carboxyl groups which are then able to undergo condensation reactions with amino and hydroxyl groups, again yielding amide and ester linkages. Enzymes which are capable of cleaving such bonds include the hydrolases (EC 3.1.). General reaction schemes are shown below.
Examples of possible modifications to POO A. Preparation of POO acid chloride
PQQ PQQ acid chloride B. Reaction of an acid chloride with: (i) an amine
(ii) an alcohol
C. Carbodiimide initiated condensation reactions (i) Acylation of amines
(ii) Esterification with hydroxy groups
Since acid chlorides are highly reactive species, it is sometimes necessary to prevent PQQ acid chloride molecules from reacting with each other. This can be achieved by chemically "protecting" any susceptible groups or alternatively by immobilising it on a solid phase prior to the modification reactions to ensure that PQQ interactions cannot occur.
The nature of the R group will depend on the specificity of the enzyme chosen as the primary amplification label. For example, aminoacylase (EC 3.5.1.14) will cleave amide bonds of N-acyl amino acids. Thus POQ which has been modified with, for example, L-methionine (as shown below) might serve as a substrate for this enzyme, the activity of which would yield native PQQ provided that the nature of the R' group (PQQ) is not a critical factor in substrate binding.
0 R'- + H2N-CH-CO [protecting group] OH (CH2)2 S CH3 (PQQ) (L-methionine) + carbodiimide H20 o Ii R C - NH- CiH - CO [protecting group] (CH2)2 S CH3 When preparing the L-methionine derivative of PQQ, the carboxyl group of the methionine is protected, so as to prevent condensation of amino acid molecules with each other.
The above represents only one of the possible routes to achieving a derivative. Alternatives include modifying the orthoquinone moiety of PQQ which has been shown to be essential for activity or the preparation of analogues by, for example, synthetic pathways.
REFERENCES D'Costa,E.J. Ph.D. Thesis, Cranfield Institute of Technology (1986).
D'Costa,E.J., Higgins,l.J. and Turner,A.P.F.; "Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor."; Biosensors (1986) 2, 71-87.
D'Costa,E.J., Turner,A.P.F., Higgins,l.J., Duine,J.A. and Dokter,P.; "Kinetics of a microbial quinoprotein glucose dehydrogenase."; Soc.Gen.Microbiol.Quart. (1984) 11(1).
Conlin,M., Forrest,H.S. and Bruice,T.C.; "Replacement of methoxatin by 4,7-phenanthroline-5,6dione and the inability of other phenanthroline quinones, as well as 7,9-didecarboxy methoxatin, to serve as cofactors for the methoxatin-requiring glucose dehydrogenase of Acinetobactor calcoaceticus."; Biochem.Biophys.Res.Comm. (1985) 131(2), 564-566.
Eckert,T.S. and Bruice,T.C.; "Chemical properties of phenanthroline quinones and the mechanism of amine oxidation by o-quinones of medium redox potentials."; J.Am.Chem.Soc. (1983) 105, 4431-4441.
Sleath,P.R., Noar,J.B., Eberlein,G.A. and Bruice,T.C.; "Synthesis of 7,9-didecarboxymethoxatin (4, 5-dihydro-4, 5-dioxo- 1 H-pyrrolo[2,3-f]quinoline-2carboxylic acid) and comparison of its chemical properties with those of methoxatin and analogous o-quinones. Model studies directed toward the action of PQQ-requiring bacterial oxidoreductases and mammalian plasma amine oxidases."; J.Am.Chem.Soc. (1985) 107, 3328-3338.
Dekker,R.H., Duine,J.A., Frank,Jzn.J., Verweil,P.E.J. and Westerling,J.; "Covalent addition of H2O, enzyme substrates and activators to pyrrolo-quinoline quinone, the coenzyme of quinopro teins."; Eur.J.Biochem. (1982) 152, 69-73.
Duine,J.A., Frank,Jzn.J. and Jongjan,J.A.; "Detection and determination of pyrrolo-quinoline quinone, the coenzyme of quinoproteins."; Anal.Biochem. (1983) 133, 239-243.
Buchi,G., Botkin,J.H., Lee,G.C.M. and Yakushijin,K.; "A synthesis of methoxatin."; J.Am.
Chem.Soc. (1985) 107, 5555-5556.
MacKenzie,A.R., Moody,C.J. and Rees,C.W.; "Synthesis of the bacterial coenzyme methoxatin."; J.Chem.Soc.; Chem.Comm. (1983), 1372-1373.
Hendrickson,J.B. and De Vries,J.G.; "Total synthesis of the novel coenzyme, methoxatin."; J.Org.Chem. (1985) 50, 1688-1695.
Gainor,J.A. and Weinreb,S.M.; "Total synthesis of methoxatin, the coenzyme of methanol dehydrogenase and glucose dehydrogenase. ; J.Org.Chem. (1981) 46, 4317-4319.
Corey,E.J. and Tramontano,A.; "Total synthesis of the quinonoid alcohol dehydrogenase coenzyme (1) of methylotropic bacteria."; J.Am.Chem.Soc. (1981) 103, 5599-5600.
Duine,J.A., Frank,Jzn.J. and Verweil,P.E.J.; "Structure and activity of the prosthetic group of methanol dehydrogenase."; Eur.J.Biochem. (1980) 108, 187-192.
Salisbury,S.A., Forrest,H.S., Cruse,W.B.T. and Kennard,O.; "A novel coenzyme from bacterial primary alcohol dehydrogenase."; Nature (1979) 280, 843-844.
van Schie,B.J., van Dijken,J.P. and Kuenen,J.G.; "Non-coordinated synthesis of glucose dehydrogenase and its prosthetic group, PQQ, in Acinetobacter and Pseudomonas species."; FEMS.Microbiol.Letts. (1984) 24, 133-136.
Hauge,J.G.; "Purification and properties of glucose dehydrogenase and cytochrome b from Bacterium anitratum."; Biochem. Biophys.Acta. (1960) 45, 250-262.
Duine,J.A. and Frank,Jzn.J.; "Quinoproteins: a novel class of dehydrogenases."; Trends in Biochem. Sci. (1981) 6, 278-280.

Claims (7)

1. A specific binding assay for an analyte which comprises: (a) binding of a specific binding pair (sbp) to an extent related to the presence of the analyte, which sbp comprises an enzyme; (b) release of a co-enzyme from a derivative thereof by the action of said enzyme, the derivative being a substrate for said enzyme; (c) re-constitution of a holo-enzyme from the co-enzyme and an apo-enzyme; and (d) detection of the holo-enzyme; wherein the co-enzyme derivative does not combine with the apo-enzyme to reconstitute substantial holo-enzyme activity; said coenzyme being 2,7,9-tricarboxy-1 H-pyrrolo-(2,3-l)-quinoline-4,5-dione (pyrroloquinoline quinone) (PQQ) or an analogue thereof which reconstitutes holo-enzyme activity, and the apoenzyme is a quinoprotein.
2. An assay according to claim 1 wherein the specific binding pair comprises an immobilised binding member specific for an analyte and a second binding member conjugated to an enzyme.
3. An assay according to claim 2 wherein the second binding member is either specific for the immobilised binding member or the analyte.
4. An assay according to claim 3 wherein the second binding member competes with the analyte for conjugation with the immobilised binding member, or the immobilised binding member competes with the analyte for conjugation with the second binding member.
5. An assay according to claim 3 wherein the analyte contains a site which binds specifically to the immobilised binding member and a different site which binds specifically to the second binding member.
6. An assay according to claim 1 substantially as described herein.
7. A kit for an assay of any one of the preceding claims.
GB08708200A 1986-04-07 1987-04-06 Specific binding assays Withdrawn GB2188728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868608435A GB8608435D0 (en) 1986-04-07 1986-04-07 Specific binding assays

Publications (2)

Publication Number Publication Date
GB8708200D0 GB8708200D0 (en) 1987-05-13
GB2188728A true GB2188728A (en) 1987-10-07

Family

ID=10595807

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868608435A Pending GB8608435D0 (en) 1986-04-07 1986-04-07 Specific binding assays
GB08708200A Withdrawn GB2188728A (en) 1986-04-07 1987-04-06 Specific binding assays

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB868608435A Pending GB8608435D0 (en) 1986-04-07 1986-04-07 Specific binding assays

Country Status (1)

Country Link
GB (2) GB8608435D0 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999019507A1 (en) * 1997-10-16 1999-04-22 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
WO2003097863A1 (en) 2002-05-16 2003-11-27 F. Hoffmann-La Roche Ag Method and reagent system having an inactivated enzyme
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
WO2005111230A2 (en) * 2004-03-03 2005-11-24 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US7172890B2 (en) 2004-10-28 2007-02-06 Roche Diagnostics Gmbh Inactivated enzyme variants and associated process and reagent system
EP1801229A1 (en) * 1997-10-16 2007-06-27 Abbott Laboratories Biosensor electrode
US7758812B2 (en) 2001-12-22 2010-07-20 Roche Diagnostics Operations, Inc. Analysis system for determining an analyte concentration, taking into consideration sample-and analyte-independent light-intensity changes
US8118991B2 (en) 2001-09-04 2012-02-21 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2023607A (en) * 1978-06-22 1980-01-03 Miles Lab Specific Binding Assay Method With a Prosthetic Group as a Label Component
EP0094161A1 (en) * 1982-05-07 1983-11-16 Imperial Chemical Industries Plc Method for determining glucose content of fluid
EP0125867A2 (en) * 1983-05-05 1984-11-21 MediSense, Inc. Assay systems using enzymes requiring NAD(P) as cofactor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2023607A (en) * 1978-06-22 1980-01-03 Miles Lab Specific Binding Assay Method With a Prosthetic Group as a Label Component
EP0094161A1 (en) * 1982-05-07 1983-11-16 Imperial Chemical Industries Plc Method for determining glucose content of fluid
EP0125867A2 (en) * 1983-05-05 1984-11-21 MediSense, Inc. Assay systems using enzymes requiring NAD(P) as cofactor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANALYST (LONDON)VOL. 110 (8)P 925-8 *
ANALYTICAL BIOCHEMISTRY VOL. 151 (2)P 263-67 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119795A1 (en) * 1997-10-16 2009-11-18 Abbott Laboratories Biosensor electrode
US8241485B2 (en) 1997-10-16 2012-08-14 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US8221612B2 (en) 1997-10-16 2012-07-17 Abbott Diabetes Care Inc. Biosensor electrode mediators for regeneration of cofactors
US8012341B2 (en) 1997-10-16 2011-09-06 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US7998337B2 (en) 1997-10-16 2011-08-16 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
WO1999019507A1 (en) * 1997-10-16 1999-04-22 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
EP1801229A1 (en) * 1997-10-16 2007-06-27 Abbott Laboratories Biosensor electrode
US7504019B2 (en) 1997-10-16 2009-03-17 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US8118991B2 (en) 2001-09-04 2012-02-21 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US7758812B2 (en) 2001-12-22 2010-07-20 Roche Diagnostics Operations, Inc. Analysis system for determining an analyte concentration, taking into consideration sample-and analyte-independent light-intensity changes
JP4656938B2 (en) * 2002-05-16 2011-03-23 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Method and reagent system using inactivated enzyme
JP2005528897A (en) * 2002-05-16 2005-09-29 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Method and reagent system using inactivated enzyme
WO2003097863A1 (en) 2002-05-16 2003-11-27 F. Hoffmann-La Roche Ag Method and reagent system having an inactivated enzyme
WO2005111230A3 (en) * 2004-03-03 2007-02-01 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US7166208B2 (en) * 2004-03-03 2007-01-23 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
WO2005111230A2 (en) * 2004-03-03 2005-11-24 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US7517664B2 (en) 2004-10-28 2009-04-14 Roche Diagnostics Operations, Inc. Inactivated enzyme variants and associated process and reagent system
US7172890B2 (en) 2004-10-28 2007-02-06 Roche Diagnostics Gmbh Inactivated enzyme variants and associated process and reagent system

Also Published As

Publication number Publication date
GB8708200D0 (en) 1987-05-13
GB8608435D0 (en) 1986-05-14

Similar Documents

Publication Publication Date Title
CA1218704A (en) Assay systems using more than one enzyme
McNeil et al. Thermostable reduced nicotinamide adenine dinucleotide oxidase: application to amperometric enzyme assay
Ianniello et al. Immobilized enzyme chemically modified electrode as an amperometric sensor
JP3242923B2 (en) Electrode and method for detecting hydrogen peroxide
US4321123A (en) Coenzyme immobilized electrode
US4840893A (en) Electrochemical assay for nucleic acids and nucleic acid probes
Charpentier et al. Amperometric determination of cholesterol in serum with use of a renewable surface peroxidase electrode
US5387515A (en) Process for providing a 6-ketone from morphine or an ether derivative thereof using morphine dehydrogenase
Villalonga et al. Construction of an amperometric biosensor for xanthine via supramolecular associations
JPH05507195A (en) Substrate regeneration type biosensor
Mizutani et al. Amperometric glucose-sensing electrode based on carbon paste containing poly (ethylene glycol)-modified glucose oxidase and cobalt octaethoxyphthalocyanine
Montagné et al. Bi-enzyme amperometric d-lactate sensor using macromolecular NAD+
GB2188728A (en) Specific binding assays
Arai et al. Electrochemical characteristics of D-amino acid oxidase immobilized in a conductive redox polymer
Yao et al. Amperometric enzyme-immunosensor based on ferrocene-mediated amplification
Loughran et al. Amperometric detection of histamine at a quinoprotein dehydrogenase enzyme electrode
JPS5816693B2 (en) electrode
CA1130739A (en) Lactate oxidase, process for manufacture thereof and analytical method and kit for the use of the same
JPS6279780A (en) Quantitative determination of 1,5-anhydroglucitol, enzyme used therefor and production thereof
ERDEM et al. Electrochemical biosensor based on horseradish peroxidase for the determination of oxidizable drugs
Kelly et al. Amperometric immunosensor for lactate dehydrogenase LD-1
Chang et al. Immobilized-enzyme electrode for nicotinamide adenine dinucleotide (reduced form)(NADH) sensing and application to the kinetic studies of NADH dependent dehydrogenases
Stoytcheva Electrocatalysis with an acetylcholinesterase immobilized graphite electrode
Yabuki et al. Choline-sensing electrode based on polyethylene glycol-modified enzyme and mediator
JPS6017346A (en) Inspection method using one kind or more of enzyme

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)